Clinical Trials
5
Active:2
Completed:1
Trial Phases
1 Phases
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (100.0%)DurAVR™ THV EU-EFS
Not Applicable
Not yet recruiting
- Conditions
- Symptomatic Aortic StenosisAortic Valve DiseaseSevere Aortic Valve StenosisAortic Valve FailureAortic Valve Calcification
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Anteris Technologies Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06510855
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
Not Applicable
Active, not recruiting
- Conditions
- Symptomatic Aortic StenosisAortic StenosisSevere Aortic Valve StenosisAortic Valve Calcification
- First Posted Date
- 2023-02-03
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Anteris Technologies Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT05712161
- Locations
- 🇺🇸
Tucson Medical Center, Tucson, Arizona, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States
DurAVR™ THV System: First-In-Human Study
Not Applicable
Active, not recruiting
- Conditions
- Aortic Valve CalcificationSevere Aortic Valve StenosisSymptomatic Aortic Stenosis
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Anteris Technologies Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT05182307
- Locations
- 🇬🇪
Tbilisi Heart and Vascular Clinic Ltd, Tbilisi, Georgia
First in Human Feasibility Study With ADAPT 3D - ALR for Aortic Leaflet Repair
Not Applicable
- Conditions
- Aortic InsufficiencyAortic Stenosis
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- Anteris Technologies Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT04178213
- Locations
- 🇧🇪
University Hospital Leuven, Leuven, Belgium
CardioCel Tri-leaflet Repair Study
Not Applicable
Completed
- Conditions
- Aortic StenosisAortic Insufficiency
- First Posted Date
- 2015-12-14
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- Anteris Technologies Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT02629328
- Locations
- 🇧🇪
Universtiy Hospital Leuven, Leuven, Belgium
News
No news found